Therapeutics Initiative

🆕 UBC TI Therapeutics Letter 157: How to🛑antidepressants 👉ti.ubc.ca/letter157 🐌 Avoid abrupt discontinuation 🖥️ Monitor patients after dose reduction 👩🏽‍🏫 Patient education + shared decision-making to minimize harms, improve outcomes #deprescribing #MedEd #antidepressants

🚨UBC TI Therapeutics Letter 157: How to 🛑 antidepressants 👉 ti.ubc.ca/letter157 Check out our patient handout on stopping #antidepressants! 👇 #MedEd #patienteducation #deprescribing #patientsafety

🆕 UBC TI Therapeutics Letter 157: How to 🛑 antidepressants 👉 ti.ubc.ca/letter157 Check out our patient handout on stopping #antidepressants!👇 #MedEd #patienteducation #deprescribing #patientsafety

ICYMI: TI Therapeutics Letter 157: How to🛑antidepressants 👉ti.ubc.ca/letter157 🐌 Avoid abrupt discontinuation 🖥️ Monitor patients after dose reduction 👩🏽‍🏫 Patient education + shared decision-making to minimize harms, improve outcomes #deprescribing #MedEd #antidepressants

ICYMI: Talking to patients about #Antibiotics🚨 Patient handout: When Are Oral Antibiotics the Right Choice? ti.ubc.ca/antibiotics-in… 👉🏼See also our TI Letter 155: ti.ubc.ca/Letter155 #PatientEducation #MedEd #prescribing

Really important Letter from @Drug_Evidence outlining how to safely taper, including hyperbolic approaches, drawing from the Maudsley Deprescribing Guidelines approach.

🚨 UBC TI Therapeutics Letter 157: How to🛑antidepressants 👉ti.ubc.ca/letter157 🐌 Avoid abrupt discontinuation 🖥️ Monitor patients after dose reduction 👩🏽‍🏫 Patient education + shared decision-making to minimize harms, improve outcomes #deprescribing #MedEd #antidepressants

ICYMI: TI #BestEvidence webinar recording: Oral vs IV Antibiotics ti.ubc.ca/antibiotics-we… See also: TI Therapeutics Letter on #antibiotics: ti.ubc.ca/letter155 Patient handout: When are oral antibiotics the right choice? ti.ubc.ca/antibiotics-in… #MedEd #BetterPrescribing

🚨TI #BestEvidence webinar recording 🚨 Highlights from TI Portrait Featuring the TI's Dr. Aaron Tejani 👉 youtube.com/watch?v=-5V9YP… Sign up for TI Portrait here: ti.ubc.ca/portrait #prescribing #MedEd #BetterPrescribing

🆕 TI #BestEvidence webinar recording 🆕 Highlights from TI Portrait Featuring the TI's Dr. Aaron Tejani @amtejani.bsky.social 👉 youtube.com/watch?v=-5V9YP… Sign up for TI Portrait here: ti.ubc.ca/portrait #prescribing #MedEd #BetterPrescribing

🚨 ICYMI - Diagnostic test accuracy #MetaAnalysis methods View the recording: ti.ubc.ca/2023/05/17/dta… #ResearchMethods #NetworkMetaAnalysis

🚨 TI #BestEvidence webinar recording: Do your (es)citalopram prescriptions cost more than they're worth? 👉Video: youtube.com/watch?v=KWUikN… #citalopram #escitalopram #prescribing

🆕 TI #BestEvidence webinar recording: Do your (es)citalopram prescriptions cost more than they're worth? 👉Video: youtube.com/watch?v=KWUikN… #citalopram #escitalopram #prescribing

🧵 Come work with us! 1/ The UBC Therapeutics Initiative seeks talented, energetic and dedicated individuals to join our team!

🚨ICYMI - TI #BestEvidence webinar Addressing medications that are ineffective & potentially harmful for patients with alcohol & other substance use disorders 💊🍻🚬 ti.ubc.ca/harms-aud-sud/ Speaker: Dr. Evan Wood #polypharmacy #alcohol #substanceusedisorder

🚨ICYMI: TI Methods Speaker Series webinar: Basics of Patient-Oriented Research: A case study in #PatientEngagement in Transplant Research 👉Webinar recording: bit.ly/3brWsje #patients #ResearchMethods

Therapeutics Letter 153: Triple terapia para la EPOC: es complicado entender la evidencia ti.ubc.ca/es/2025/03/17/… La evidencia actual no respalda la triple terapia como primera línea en pacientes con EPOC sin tratamiento previo

🚨TI Therapeutics Letter 154: Navegando las pruebas tiroideas en el hipotiroidismo primario 👉🏽 ti.ubc.ca/es/2025/04/22/… #SegPac #hipotiroidismo #MedEd